Search PubMed⌕ Search

Biomedical subjects

R F Shangraw

Publications and source records attributed to R F Shangraw.

At least 19 recordsLinked to original sources

Production of inert cushioning beads: effect of excipients on the physicomechanical properties of freeze-dried beads containing microcrystalline cellulose produced by extrusion-spheronization.

Conventional highly compactible fillers such as microcrystalline cellulose (MCC) can be mixed with drug-loaded membrane-coated beads and compressed to form a tablet. However, due to particle size differences, there is substantial risk of segregation leading to weight variation and content uniformity problems. Furthermore, whenever modified release beads are included in a tablet matrix, care must be taken to assure the integrity of the coated beads. This paper describes the development of placebo beads containing MCC whose properties make them uniquely suitable for tableting modified release beads. These placebo beads have high compactibility and the ability to rapidly disintegrate. They deform readily and may provide a high degree of protection to drug-loaded membrane-coated beads during compression ('cushioning effect'). They can be produced in size ranges that provide minimal segregation propensity. Beads containing different MCC/lactose ratios and different types and levels of superdisintegrants were produced by extrusion-spheronization followed by freeze drying. The presence of high levels of MCC and different superdisintegrants, especially croscarmellose sodium, increased the granulation liquid requirement, thus producing freeze-dried beads with higher porosities and compactibility. Athy-Heckel analysis studies revealed that beads rich in MCC exhibited lower mean yield pressures than those containing high levels of lactose. The freeze-dried beads exhibited both plastic deformation and brittle fracture characteristics.

Cellulose↗

The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.

The objective of this study was to examine the influence of intra- and extragranular microcrystalline cellulose (MCC) on drug dissolution from tablets made by high-shear granulation. Granulations were made in a Littleford Model W-10-B (10-liter) mixer and dried in a fluid bed dryer (Niro Inc.). A Plackett-Burman screening design and 2(3) factorial design were employed to study how drug type, MCC (intra- or extra-), filler type (lactose or dicalcium phosphate), disintegrant type (sodium starch glycolate or croscarmellose sodium) and level, proportion of magnesium stearate, and impeller speed affect tablet hardness, disintegration time, and dissolution. Two model drugs were chosen based on their solubility: metoprolol tartrate (solubility > 1000 mg/ml) and hydrochlorothiazide (solubility = 1.05 mg/ml). Tablets were compressed to the same target weight (dose) and similar tablet hardness. In some cases, dissolution testing was also carried out on the loose granules. The intra-extragranular distribution of MCC was found critical to the compactibility and initial dissolution rates from these tablets. Intragranular MCC reduced drug dissolution, the effect being most marked in the case of the slightly soluble hydrochlorothiazide. For formulations containing intragranular MCC, the granulating fluid level on tablet dissolution was also important, since an increase in fluid level resulted in slower drug dissolution from both the loose granules and the tablets compressed from them. Conversely, extragranular MCC tended to increase both dissolution rates and compactibility. It may be concluded that the appropriate distribution of MCC between and within granules may optimize both dissolution and compactibility without changing overall tablet composition.

Cellulose↗

Variable efficacy of calcium carbonate tablets.

Orally administered calcium carbonate tablets are commonly prescribed as a calcium supplement and for their phosphate-binding effects in renal failure patients. Two cases are reported in which a commercially available brand of calcium carbonate tablets appeared to be ineffective. Formal investigation of the bioavailability of this product revealed it to have impaired disintegration and dissolution and a lack of clinical efficacy. Recommendations that will enable physicians to avoid prescribing and pharmacists to avoid dispensing ineffective calcium carbonate tablets are proposed.

Adult↗

Thiazides. VIII: Dissolution survey of marketed hydrochlorothiazide tablets.

The dissolution profiles of 50-mg hydrochlorothiazide tablets representing all approved manufacturers (at the time of the study) were determined in two vehicles [purified water and dilute (1:100) hydrochloric acid] by three methods (rotating basket at 150 rpm; spin filter at 300 rpm; paddle method at 50 rpm). The paddle method was preferred on the basis of overall ease of operation, reproducibility, and discrimination. The paddle data were validated in both vehicles on the same lots of tablets by a second laboratory. A standard of not less than 80% dissolution in 60 min by the paddle method in water is proposed for hydrochlorothiazide tablets.

Chemistry, Pharmaceutical↗

Stability of nitroglycerin tablets in a unit of use pendant-type container.

A stainless steel pendant (Life-Link) designed to carry emergency quantities of nitroglycerin tablets was examined for compliance with FDA packaging restrictions for nitroglycerin. The results of the study indicate that the pendant is equal or superior to screw-capped glass containers presently required for packaging of nitroglycerin tablets. Tablets stored for up to 3 months retain potency and physical integrity. The pendant provides a simple, tight, convenient, and unbreakable container for carrying nitroglycerin tablets on a 24-hour basis.

Drug Packaging↗

Moisture permeation of typical unit does repackaging materials.

The moisture permeation of unit does repackaging materials used by various hospital and community pharmacies in a metropolitan area was studied. Commercial desiccant pellets were packaged in the same manner used for ordinary tablets and capsules. The samples were weighed and placed in a controlled chamber at about 75% relative humidity and 22 C, and tested for weight gain over a period of 4-10 days. Four types of packages were evaluated: (1) heat-sealed polyethylene bag, (2) polyvinyl chloride cups adhesive-sealed to multiple-ply paper, (3) heat-sealed "polycel-polyfoil" strip packages and (4) polyvinyl chloride/foil multiple-cup blister packs. A wide range of results was found. None of the containers tested was a good moisture barrier, although some offered protection for a limited time. Several needs were identified by this survey. Pharmacists need more information and an increased awareness concerning the permeation characteristics of repackaging materials, suitable operating procedures and the stability of pharmaceutical products. Standards must be established for repackaging materials as well as limits on storage periods for the repackaged pharmaceuticals. Procedures for pharmacists to test their own packaging systems, and a checklist of some important guidelines for repackaging in unit dose containers, are presented.

Drug Packaging↗